| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |